Exploring the Interactions between Mycobacterium tuberculosis and the Host Immune System in Chronic Infection

Jianhong Xu^* and Lianying Zhou
^*Correspondence: Jianhong Xu, Department of Microbiology, Shanghai Medical College, Yangpu District, Shanghai, China, Email:

Introduction

Mycobacterium Tuberculosis (M. tuberculosis), the causative agent of Tuberculosis (TB), continues to represent a major global health concern, despite significant advances in medical science. TB remains one of the leading causes of infectious disease mortality worldwide, with the World Health Organization (WHO) estimating over 10 million new TB cases and nearly 1.5 million deaths annually. The pathogenesis of TB is complex, involving intricate interactions between the host immune system and the bacterium. After initial exposure to M. tuberculosis, the host immune system engages in a series of responses aimed at containing and eliminating the pathogen. However, M. tuberculosis has evolved various strategies to subvert these immune defenses, often resulting in the persistence of the bacteria within the host, leading to Latent Tb Infection (LTBI) [1].

The ability of M. tuberculosis to remain dormant for years and re-activate when the immune system weakens is a hallmark of the disease, contributing to its chronic nature. This article explores the immune mechanisms underlying the establishment and maintenance of chronic M. tuberculosis infection, focusing on the role of innate and adaptive immune responses, granuloma formation, and the factors that influence immune control and bacterial persistence.

Description

Immune evasion and survival mechanisms of M. tuberculosis

The interaction between M. tuberculosis and the host immune system is multifaceted and begins immediately after the bacterium enters the lungs. Upon inhalation, M. tuberculosis encounters alveolar macrophages, the primary phagocytic cells responsible for pathogen clearance. These macrophages are a key component of the host’s innate immune defense and attempt to engulf and destroy the bacteria. However, M. tuberculosis has developed several strategies to evade destruction. One of the most significant mechanisms is its ability to inhibit the fusion of the phagosome with the lysosome, thus preventing the bacterium from being killed by reactive oxygen species and acidic environments within the lysosome. Additionally, M. tuberculosis produces various immunomodulatory lipids and proteins that interfere with macrophage activation, suppressing inflammatory responses and allowing the pathogen to persist. Beyond the macrophage, M. tuberculosis also interacts with other cells of the innate immune system, such as dendritic cells and neutrophils. Dendritic cells are crucial for the initiation of adaptive immunity, as they capture mycobacterial antigens and present them to naïve T cells [2]. However, M. tuberculosis can manipulate dendritic cell function, often impairing antigen presentation and the activation of T cell responses. In the case of neutrophils, which are involved in early-stage bacterial clearance, M. tuberculosis can delay neutrophil apoptosis, enabling extended survival of infected neutrophils in the lung, which contributes to tissue damage and the spread of infection.

Granuloma formation and the role of adaptive immunity

While the innate immune response often fails to eradicate M. tuberculosis, it triggers a robust adaptive immune response that is essential for controlling the infection. The hallmark of adaptive immunity in TB infection is the formation of granulomas, which are organized aggregates of immune cells, including macrophages, dendritic cells, T cells, and fibroblasts. Granulomas form as a result of the immune system's attempt to wall off the bacteria, preventing them from spreading to other parts of the body. Infected macrophages in the granuloma secrete pro-inflammatory cytokines, such as Tumor Necrosis Factor-Alpha (TNF-α) and Interferon-Gamma (IFN-γ), which recruit additional immune cells to the site of infection. While granulomas can effectively contain M. tuberculosis and limit its dissemination, they also create a microenvironment conducive to bacterial persistence. Within the granuloma, M. tuberculosis can survive in a latent state, evading immune detection and avoiding clearance by the host immune system. This latent phase of infection is characterized by metabolic dormancy, where the bacterium enters a state of reduced metabolic activity, allowing it to remain viable for extended periods [1,3]. In some cases, the granuloma fails to fully contain the bacteria, leading to reactivation of the infection, often triggered by factors such as immunosuppression, aging, or coinfection with HIV.

Factors influencing host immunity and TB chronicity

The immune response to M. tuberculosis is influenced by various host factors, including genetic susceptibility, co-infections, and overall immune status. Genetic polymorphisms in immune-related genes can impact the host’s ability to mount an effective defense against M. tuberculosis. For example, mutations in genes encoding key immune molecules like the interferongamma receptor or NOD2 (a pattern recognition receptor) have been linked to increased susceptibility to TB infection and progression to active disease. Co-infection with HIV is another major risk factor for the development of active TB, as HIV significantly weakens the immune system, particularly CD4+ T cells, which are critical for controlling M. tuberculosis infection. HIV-positive individuals are at an increased risk of developing TB due to the impairment of granuloma formation and the inability to mount an effective immune response to latent TB. Additionally, nutritional status, age, and other comorbid conditions such as diabetes mellitus can further compromise the immune system and increase the risk of TB progression [4].

Immune modulation and the role of host metabolism

Recent research has highlighted the importance of host cell metabolism in the pathogenesis of TB. M. tuberculosis can hijack host cell metabolic pathways to create a favorable environment for its survival. During infection, macrophages alter their metabolic processes to support immune responses, but M. tuberculosis can manipulate these pathways to its advantage. For instance, the bacterium induces a shift towards lipid metabolism within infected macrophages, providing an energy source that supports bacterial growth. Additionally, M. tuberculosis can exploit the host’s oxidative stress response, manipulating the production of Reactive Oxygen Species (ROS) to avoid cell death and facilitate its persistence within the host [4,5].

Conclusion

The interactions between Mycobacterium tuberculosis and the host immune system are highly complex and are central to the chronic nature of tuberculosis. While the innate immune response plays an important role in the initial containment of the pathogen, it is the adaptive immune system, particularly T cell-mediated immunity, that is critical for controlling the infection. However, the ability of M. tuberculosis to evade immune detection, manipulate immune responses, and persist in a latent state within granulomas is a major challenge in TB management.

Current therapeutic approaches, including prolonged antibiotic regimens, are often ineffective against multidrug-resistant strains of M. tuberculosis and fail to address latent infection, which is responsible for the majority of TB cases globally. Therefore, a deeper understanding of the immune mechanisms underlying TB persistence and chronicity is essential for the development of novel therapeutic and preventive strategies. Future research should focus on identifying new biomarkers for early detection, targeting host immune responses to enhance bacterial clearance, and developing vaccines that can prevent both active and latent TB. In the fight against tuberculosis, a more comprehensive understanding of host-pathogen interactions is critical for achieving better control and ultimately eliminating TB as a public health threat.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Lateef, Zainab M., Zahraa Hamid Alwan Al-Saadi and Karam R. Aljarah. "Host-pathogen interactions in M. tuberculosis: Molecular mechanisms and implications for treatment.”

Google Scholar, Crossref, Indexed at

2. Abbasnia, Shadi, Amir Mohammad Hashem Asnaashari, Hiva Sharebiani and Saman Soleimanpour, et al. "M. tuberculosis and host interactions in the manifestation of tuberculosis." J Clin Tuberc Other Mycobact Dis 36 (2024): 100458. 

Google Scholar, Crossref, Indexed at

3. Guallar-Garrido, Sandra and Thierry Soldati. "Exploring host–pathogen interactions in the Dictyostelium discoideum–Mycobacterium marinum infection model of tuberculosis." Dis Model Mech 17 (2024): dmm050698.

Google Scholar, Crossref, Indexed at

4. Roy, Arnab, Puja Kumari Agnivesh, Shashikanta Sau and Sunil Kumar, et al. "Tweaking host immune responses for novel therapeutic approaches against M. tuberculosis." Drug Discov Today (2023): 103693.

Google Scholar, Crossref, Indexed at

5. Alipoor, Shamila D. and Daniel Elieh-Ali-Komi. "Significance of extracellular vesicles in orchestration of immune responses in M. tuberculosis infection." Front Cell Infect Microbiol 14 (2024): 1398077.

Google Scholar, Crossref, Indexed at